Latest Topiramate Stories
The Consumer Justice Foundation, a for-profit corporation that is staffed by a team of professional consumer advocates whose mission is to provide consumers with information regarding the potential
The drug retigabine (trade name: Trobalt®) was approved in March 2011 as add-on therapy for adults with epileptic seizures. In an early benefit assessment pursuant to the "Act on the Reform of the Market for Medicinal Products” (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether retigabine offers an added benefit compared with the present standard therapy.
The Consumer Justice Foundation, a for-profit corporation that is staffed by professional consumer advocates who provide free online informational resources regarding certain prescription medications
The makers of three previously rejected weight loss drugs have resubmitted their products to the Food and Drug Administration (FDA) for approval, with each hoping to become the first new prescription anti-obesity drug to be approved in the U.S. in 13 years.
Another review by the Food and Drug Administration (FDA) for a new drug yesterday resulted in a 20-2 judgment in favor of allowing Qnexa to be placed on the market to combat obesity.
A weight-loss drug currently under a second review from the Food and Drug Administration (FDA) is causing concerns that it may be responsible for birth defects and heart problems, according to documents released by the agency on Friday.
- A person who stands up for something, as contrasted to a bystander who remains inactive.
- One of the upright handlebars on a traditional Inuit sled.